Table 4 Quadruplex (n=4) pyro-signals (n=10): results of AdvISER-MH-PYRO after adjustement of primer concentrations
Patient | rs1016343 | rs10993994 | rs16901979 | rs5945619 | R a | ||||
|---|---|---|---|---|---|---|---|---|---|
Genotype | Contribution a (%) | Genotype | Contribution a (%) | Genotype | Contribution a (%) | Genototype | Contribution a (%) | ||
1 | C/C | 4.36 (18.6) | T/T | 2.87 (12.2) | C/C | 11.35 (48.4) | T | 4.85 (20.7) | 0.999 |
2 | C/C | 5.52 (20.5) | C/C | 7.05 (26.2) | C/C | 10.71 (39.8) | T | 3.66 (13.6) | 0.998 |
3 | C/C | 4.58 (19.6) | C/C | 3.66 (15.6) | C/C | 11.09 (47.4) | C | 4.09 (17.5) | 0.999 |
4 | C/C | 2.85 (16.4) | C/C | 2.23 (12.8) | C/C | 9.78 (56.1) | T | 2.57 (14.7) | 0.999 |
5 | C/C | 4.97 (18.8) | C/T | 5.34 (20.2) | C/C | 10.63 (40.3) | T | 5.44 (20.6) | 0.999 |
6 | T/T | 3.92 (16.3) | C/T | 4.93 (20.5) | C/C | 10.2 (42.5) | T | 4.95 (20.6) | >0.999 |
7 | C/C | 3.98 (17.9) | C/T | 3.87 (17.4) | C/C | 10.23 (45.9) | T | 4.2 (18.9) | 0.997 |
8 | C/T | 4.87 (18.3) | C/T | 5.19 (19.5) | A/A | 12.41 (46.6) | T | 4.18 (15.7) | 0.999 |
9 | C/C | 3.05 (18.4) | C/C | 1.82 (11.0) | C/C | 9.18 (55.3) | C | 2.56 (15.4) | 0.999 |
10 | C/C | 2.72 (16.2) | C/C | 2.35 (14.0) | C/C | 9.29 (55.2) | T | 2.46 (14.6) | >0.999 |
Average | 18.1 | 16.9 | 47.7 | 17.2 | |||||